Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 30, 2010

Premium

Mersana Therapeutics, which is developing its proprietary Fleximer polymer technology for siRNA delivery, has appointed board member Nicholas Bacopoulos as its president and CEO.

Bacopoulos previously served as president and CEO of Aton Pharma, which was acquired by Merck. Before that, he was president and head of research and development at OSI Pharmaceuticals.

He has a BA from Cornell College and a PhD from the University of Iowa.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.